Why is Venmax Drugs falling/rising?

As of 21-Aug, Venmax Drugs & Pharmaceuticals Ltd is experiencing a price increase, with the current price at Rs. 30.00, reflecting a rise of 0.9 or 3.09%. The stock has recently hit a new 52-week and all-time high of Rs. 31.95, indicating strong upward momentum. Over the past week, the stock has gained 3.81%, and in the last month, it has increased by 8.62%. Additionally, the stock has outperformed its sector by 2.63% today and has shown consecutive gains over the last three days, accumulating a total return of 6.01%. However, there has been a decline in investor participation, with delivery volume dropping by 10.41% compared to the five-day average, which may indicate some caution among investors.
Broader Market Context: In comparison to the benchmark Sensex, which has risen by 1.74% over the past week and has shown a slight decline of 0.24% over the past month, Venmax Drugs has significantly outperformed, showcasing its strength in the market. Year-to-date, while the stock has surged by 66.30%, the Sensex has only increased by 4.94%. This substantial outperformance suggests that Venmax Drugs is gaining investor confidence, despite the recent drop in delivery volume, which could be a point of concern for future trading activity.